Navigation Links
Trius Reports New Findings on Mechanisms of Antibiotic Resistance in MRSA
Date:9/13/2010

SAN DIEGO, Sept. 13 /PRNewswire-FirstCall/ -- Trius Therapeutics, Inc. (Nasdaq: TSRX) today reported  new findings on torezolid phosphate (TR-701), a second generation oxazolidinone antibiotic now in Phase 3 clinical development. The data elucidate the mechanism by which torezolid retains full activity against clinical isolates of Staphylococcus aureus (S. aureus) carrying the cfr gene which confers resistance to first generation oxazolidinones such as linezolid, marketed by Pfizer as Zyvox®.  Hospital outbreaks of linezolid resistant cfr strains of methicillin resistant Staphylococcus aureus (MRSA) have been reported worldwide and increasing use of linezolid may promote further dissemination of this plasmid borne resistance gene. Two separate articles featuring discussion of these data have been published online ahead of print on September 13 in Antimicrobial Agents and Chemotherapy (AAC), a peer-reviewed journal of the American Society for Microbiology.

S. aureus that express the cfr gene possess ribosomes that are structurally altered in a way that inhibits the binding of first generation oxazolidinone antibiotics such as linezolid, as well as the binding of antibiotics of other classes, such as the pleuromutilins, phenicols, lincosamides, and streptogramins. Torezolid's potent activity is preserved against cfr strains of S. aureus due to its unique structural features.

"Recent outbreaks of cfr strains of MRSA have fueled concerns that this pathogen will inevitably proliferate given the broad usage of linezolid and generic antibiotics that select for the plasmid borne cfr resistance gene," said Jeffrey Stein, Ph.D., President and Chief Executive Officer of Trius and corresponding author on the papers.  "The potent activity of torezolid against cfr-positive bacteria diff
'/>"/>

SOURCE Trius Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Trius to Present at the Stifel Nicolaus Healthcare Conference
2. Trius Therapeutics Obtains Special Protocol Assessment With FDA for Phase 3 Study of Torezolid Phosphate
3. Trius Therapeutics Files Registration Statement for Proposed Initial Public Offering
4. Trius Torezolid Antibiotic for the Treatment of Severe Skin Infections Featured at ICAAC Meeting
5. Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections
6. Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases
7. Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections
8. Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA
9. Trius Doses First Patient in Antibacterial Phase 2 Trial
10. PacificGMP Completes GMP Product Fill for Trius Therapeutics
11. Trius Initiates U.S. Phase I Trial for its Oxazolidinone Antibacterial Drug, TR-701
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  MGC Diagnostics Corporation (NASDAQ: ... medical technology company, today scheduled a conference call to ... fiscal year 2013, ended April 30, 2013. The call ... 30, 2013. The Company will report financial results for ... markets close on Thursday, May 30, 2013. ...
(Date:5/23/2013)...  TeamHealth Medical Call Center (THMCC), a premier ... lines, announces its newly formed Clinical Advisory Committee. ... leaders, provides clinical expertise to advance THMCC,s purpose ... hospital clients, physician clients and patients. ... imperative to continuously advance our services and improve ...
(Date:5/23/2013)... , May 23, 2013 More than ... may not benefit from chemotherapy and still have excellent ... launch of one of the largest sources of online ... website and interactive Facebook page provide recently diagnosed women ... can safely avoid chemotherapy. "We anticipate these ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2TeamHealth Medical Call Center Forms Clinical Advisory Committee 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3
... -- Concord Medical Services Holdings Limited ("Concord Medical" or the ... largest network of radiotherapy and diagnostic imaging centers in China, ... 30th Annual J.P. Morgan Healthcare Conference to be held on ... San Francisco. The Company,s management is scheduled ...
... BERLIN, Dec. 15, 2011 InterMune, Inc. (NASDAQ: ... and Efficiency in Health Care (IQWiG) has today published its ... treatment of mild to moderate idiopathic pulmonary fibrosis (IPF).  Pirfenidone ... since new healthcare legislation known as AMNOG was enacted in ...
Cached Medicine Technology:Concord Medical to Present at the 30th Annual J.P. Morgan Healthcare Conference in January 2012 2IQWIG Publishes Early Benefit Assessment for Pirfenidone 2IQWIG Publishes Early Benefit Assessment for Pirfenidone 3IQWIG Publishes Early Benefit Assessment for Pirfenidone 4
(Date:5/25/2013)... Dr. Leslie Gerstman announced today ... lift skin on the neck, on the brow and under ... Aesthetics. , Ultherapy is a non-surgical procedure for the face ... to lift the skin over time. The use of FDA-cleared ... and then treat the deepest support layers of the skin ...
(Date:5/25/2013)... May 25, 2013 Actos lawsuit ... in U.S. District Court, Western District of Louisiana, continue ... to a Case Management Order issued on May 21st, ... of contested motions in the Actos bladder cancer litigation, ... re: Actos Product Liability Litigation, MDL No. 2299) , ...
(Date:5/25/2013)... TX (PRWEB) May 25, 2013 Studies ... those who are carrying excessive weight and their inability ... for many, simply losing weight can naturally relieve many ... found that improvement in sleep quality was significantly associated ... six month study dated November 6th, 2012, ...
(Date:5/25/2013)... May 25, 2013 The latest ... from irritable bowel syndrome (IBS) to bloating, constipation, ... the most long-lasting, embarrassing, frustrating and difficult health ... for digestive health have provided a cure ... many factors contributing to digestive health issues, a ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 Dr. Farooq ... surgery clinic in Dubai, has announced his practice’s adoption ... is the only FDA-cleared femtosecond laser proven with more ... safety and precision of LASIK. , “We are happy ... Advanced Femtosecond Laser at our Dubai LASIK practice,” Ashraf ...
Breaking Medicine News(10 mins):Health News:Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2Health News:Atlanta Vision Clinic Acquires the Latest in Blade-Free Lasik Technology Bringing Dubai Patients the Intralase Method 2
... the Association of Organ Procurement Organizations (AOPO), in partnership ... factually reports on the medical miracle of donation and ... supported by the Musculoskeletal Transplant Foundation. Former winners include ... and ABC,s "Extreme Makeover: Home Edition" in 2007. , ...
... China, July 1 /PRNewswire-Asia-FirstCall/ -- Mindray Medical,International Limited (NYSE: ... of medical devices worldwide, today announced it will attend ... Chicago,Illinois from July 21st to 23rd, 2009. , ... range of 15 competitively priced in-,vitro diagnostic products at ...
... - Data published in the journal, Nicotine and Tobacco Research ... be a successful route to cessation. In the study, almost 40 ... without any advance planning, suggesting that for some smokers, setting an ... , , While a period of planning prior to quitting ...
... help Minnesotans find affordable medical, dental, and behavioral health ... PAUL, Minn., July 1 Portico Healthnet, a non-profit ... coverage for health care services, today announced the assumption ... and referral service, from the non-profit Neighborhood Health Care ...
... PARSIPPANY, N.J., July 1 Today, the Florida state tobacco tax ... history, to a total of $1.34 per pack, as part of ... tag on cigarettes may prompt Florida smokers to try and quit ... Nicotine and Tobacco Research , shows that many U.S. quit attempts ...
... , HOUSTON, July 1 Trimira LLC,s Identafi(TM) 3000 ... magazine Dentistry Today as one of its Top 100 ... published in the July issue. , , Dentistry Today ... reader response and represent what,s new and innovative in the dental ...
Cached Medicine News:Health News:Crystal Heart Award Presented to Telemundo for Coverage of Organ Donation 2Health News:Mindray to Attend the 2009 American Association for Clinical Chemistry Conference 2Health News:New Study Shows Many Unplanned Quit Smoking Attempts are Successful 2Health News:Portico Healthnet Assumes Operation of 489-CARE Information and Referral Service 2Health News:Florida State Tobacco Tax Increase May Prompt Smokers to Quit Spontaneously 2Health News:Florida State Tobacco Tax Increase May Prompt Smokers to Quit Spontaneously 3Health News:Identafi(TM) 3000 Picked by Dentistry Today Magazine as One of the Top 100 Products of 2009 2
The Livewire cannulator offers improved access to the coronary sinus by combining the ergonomic Livewire steering mechanism with numerous specialized features....
Trilogy Pacemakers incorporates the clinically proven Omniscence™ accelerometer sensor with it's automatic alogorithms. The Trilogy family of pacemakers feature an array of products for bradyar...
... pacemaker family, which includes the ... clinicians with the most advanced ... revolutionary AF Suppression™ algorithm, the ... approved algorithm designed to suppress ...
Innovative new tools for more efficient patient management begin when the pacemaker is implanted. These sophisticated tools are in effect each day, and they help automate follow-up tasks....
Medicine Products: